Literature DB >> 19433968

Impact of respiratory gating using 4-dimensional computed tomography on the dosimetry of tumor and normal tissues in patients with thoracic malignancies.

Maria Vlachaki1, Ignacio Castellon, Carlos Leite, Tania Perkins, Salahuddin Ahmad.   

Abstract

OBJECTIVE: The purpose of this study is to assess the dosimetric impact of gated CT plans on tumor and surrounding normal tissues in patients with primary thoracic malignancies.
MATERIALS AND METHODS: Ten patients underwent treatment planning with gated and nongated CT at Wayne State University. Gated CT images were obtained at full inspiration, expiration, and at the 25th, 50th, and 75th percentile of respiratory effort. Planning treatment volume (PTV) margin for nongated and gated plans was 1.5 cm and 0.5 cm, respectively. The tumor prescription dose was 60 to 70 Gy at 2 Gy per fraction.
RESULTS: Average PTV was 292.68 mL for gated and 575.17 mL for nongated plans. Gated plans resulted in higher minimum PTV doses and comparable mean and maximum doses when compared with nongated plans (53.52, 65.17, and 70.92 Gy vs. 48.06, 65.08, and 71.40 Gy, respectively). Volumes of lung receiving doses of 20 and 10 Gy or above were 26.26% and 30.96% for gated plans and 34.82% and 40.16% for nongated plans (P < 0.0001). Gated plans resulted in lower mean lung, esophageal, and heart doses compared with nongated plans (14.27, 17.28, and 10.86 Gy vs. 19.5, 21.85, and 16.45 Gy, respectively; P <or= 0.003).
CONCLUSIONS: 4-Dimensional computed tomography (4D-CT) respiratory gating significantly decreases target volumes and normal tissue dosing. With the emerging image-guided radiation therapy technology, 4D-CT treatment planning may be used for radiation dose escalation with tighter radiation fields and has the potential for improving outcomes in patients with thoracic malignancies.

Entities:  

Mesh:

Year:  2009        PMID: 19433968     DOI: 10.1097/COC.0b013e318184b33a

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  11 in total

Review 1.  Management of Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy in a Patient with Scleroderma: Case Report and Review of the Literature.

Authors:  David P Horowitz; Balazs Halmos; John Poneros; Joshua Sonett; Helen Remotti; Ryan J Burri
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Adaptive radiation for lung cancer.

Authors:  Daniel R Gomez; Joe Y Chang
Journal:  J Oncol       Date:  2010-08-04       Impact factor: 4.375

3.  Predictors of pneumonitis-free survival following lung stereotactic body radiation therapy.

Authors:  Sibo Tian; Jeffrey M Switchenko; Richard J Cassidy; Chase E Escott; Richard Castillo; Pretesh R Patel; Walter J Curran; Kristin A Higgins
Journal:  Transl Lung Cancer Res       Date:  2019-02

4.  Dosimetric study of a respiratory gating technique based on four-dimensional computed tomography in non-small-cell lung cancer.

Authors:  Hui Lin; Heming Lu; Liuyang Shu; Huixian Huang; Huasheng Chen; Jiaxin Chen; Jinjian Cheng; Qiang Pang; Luxing Peng; Junzhao Gu; Zhiping Lu
Journal:  J Radiat Res       Date:  2014-01-21       Impact factor: 2.724

5.  Effects of flattening filter-free and volumetric-modulated arc therapy delivery on treatment efficiency.

Authors:  Evan M Thomas; Richard A Popple; Brendan M Prendergast; Grant M Clark; Michael C Dobelbower; John B Fiveash
Journal:  J Appl Clin Med Phys       Date:  2013-11-04       Impact factor: 2.102

6.  Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations.

Authors:  Tania De La Fuente Herman; Maria T Vlachaki; Terence S Herman; Kerry Hibbitts; Julie A Stoner; Salahuddin Ahmad
Journal:  J Appl Clin Med Phys       Date:  2010-01-29       Impact factor: 2.102

7.  Real-time liver tracking algorithm based on LSTM and SVR networks for use in surface-guided radiation therapy.

Authors:  Guangyu Wang; Zhibin Li; Guangjun Li; Guyu Dai; Qing Xiao; Long Bai; Yisong He; Yaxin Liu; Sen Bai
Journal:  Radiat Oncol       Date:  2021-01-14       Impact factor: 3.481

8.  Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.

Authors:  Delphine Antoni; Shanti Natarajan-Ame; Philippe Meyer; Claudine Niederst; Khalil Bourahla; Georges Noel
Journal:  Radiat Oncol       Date:  2013-05-02       Impact factor: 3.481

9.  Helical tomotherapy in the radiotherapy treatment of Hodgkin's disease - a feasibility study.

Authors:  Maria T Vlachaki; Sanath Kumar
Journal:  J Appl Clin Med Phys       Date:  2010-01-28       Impact factor: 2.102

10.  Treatment of esophageal cancer with radiation therapy -a pan-Chinese survey of radiation oncologists.

Authors:  Yun Zhang; Jing Liu; Wencheng Zhang; Weiye Deng; Jinbo Yue
Journal:  Oncotarget       Date:  2017-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.